Insulet (PODD) Reports In-Line Q2 EPS, FY Revenue Guidance Beats

Go back to Insulet (PODD) Reports In-Line Q2 EPS, FY Revenue Guidance Beats

Insulet Corporation (PODD) PT Raised to $58 at Jefferies

August 4, 2017 8:38 AM EDT

Jefferies raised its price target on Insulet Corporation (NASDAQ: PODD) to $58.00 (from $48.00) while maintaining a Buy rating following the company's 2Q conference call.

The company provided more detail on the plans it announced on July 20 to abandon its distributor Ypsomed and go... More

Insulet Corporation (PODD) PT Raised to $63 at Cowen on 2Q Report; 'Direct Europe Commercialization Drives Sharp Upward Estimate Revisions'

August 4, 2017 6:42 AM EDT

Cowen raised its price target on Insulet Corporation (NASDAQ: PODD) to $63.00 (from $52.00) while maintaining a Outperform rating, following the company's second quarter earnings report.

Analyst Doug Schenkel notes the company delivered second quarter revenues above consensus projections, despite offering earnings per share results below... More